Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Daytrana now available

June 30, 2006

Mirtazapine results in obstructive sleep apnea do not warrant further studies

June 30, 2006

Gantacurium chloride completes phase II study in endotracheal intubation

June 30, 2006

ELI-154 completes second pilot phase I study

June 30, 2006

Sosei and Mundipharma sign agreement for AD-923

June 30, 2006

European approval for Tysabri in MS

June 29, 2006

Phase III program for Gabitril in GAD fails to meet endpoints

June 29, 2006

Investigational anticonvulsant increases high-voltage sleep

June 29, 2006

Sustained quality of life gains seen with rotigotine in restless legs syndrome

June 29, 2006

Exelon, first FDA approved treatment for Parkinson's disease dementia

June 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.